This study demonstrated that CD24 upregulated MET expression via the Src‐mediated downregulation of miR‐181a in serous types of ovarian cancer cells, which contributed to cellular quiescence‐like state and chemoresistance. The gene discussed is CD24; the disease is ovarian cancer.